Rhonda Janice Pacheco, President, U.S. Business Unit at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 16,901 shares at $17.10 ($289K) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Open-market sale of $289k TAK by President, U.S. Business Unit. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.